(Q29619982)

title

Progress and challenges in translating the biology of atherosclerosis (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21593864

30 April 2017

1 reference

2

Ridker PM

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21593864

30 April 2017

3

Göran K. Hansson

1 reference

21593864

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21593864

2 December 2024

author name string

Peter Libby

series ordinal

1

1 reference

21593864

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21593864

2 December 2024

Paul M. Ridker

series ordinal

2

1 reference

21593864

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21593864

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21593864

2 December 2024

language of work or name

1 reference

30 April 2017

publication date

19 May 2011

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21593864

full work available at URL

30 April 2017

http://www.nature.com/articles/nature10146.pdf

1 reference

https://api.crossref.org/works/10.1038/NATURE10146

http://www.nature.com/articles/nature10146

2 December 2024

1 reference

https://api.crossref.org/works/10.1038/NATURE10146

2 December 2024

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21593864

30 April 2017

volume

473

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21593864

30 April 2017

issue

7347

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21593864

30 April 2017

page(s)

317-25

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21593864

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

30 April 2017

cites work

1 reference

12 December 2020

Atherosclerotic lesions in mouse and man: is it the same disease?

1 reference

12 December 2020

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

1 reference

12 December 2020

Oxidized Low-Density Lipoprotein and Atherosclerosis

1 reference

12 December 2020

Macrophage death and defective inflammation resolution in atherosclerosis

1 reference

12 December 2020

The LDL modification hypothesis of atherogenesis: an update

1 reference

12 December 2020

The immune response in atherosclerosis: a double-edged sword

1 reference

12 December 2020

PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties

1 reference

12 December 2020

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

1 reference

12 December 2020

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

1 reference

12 December 2020

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

1 reference

12 December 2020

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

1 reference

12 December 2020

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

1 reference

12 December 2020

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

1 reference

12 December 2020

Vaccination against atherosclerosis? Induction of atheroprotective immunity

1 reference

12 December 2020

Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.

1 reference

12 December 2020

Association between a literature-based genetic risk score and cardiovascular events in women

1 reference

12 December 2020

Update on strategies to increase HDL quantity and function

1 reference

12 December 2020

Endothelial dysfunction, hemodynamic forces, and atherogenesis

1 reference

12 December 2020

Effects of torcetrapib in patients at high risk for coronary events

1 reference

12 December 2020

The fish story: a diet-heart hypothesis with clinical implications: n-3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death

1 reference

12 December 2020

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

1 reference

12 December 2020

Heart attacks: gone with the century?

1 reference

12 December 2020

Biomedicine. Lowering LDL--not only how low, but how long?

1 reference

12 December 2020

Natural regulatory T cells control the development of atherosclerosis in mice

1 reference

12 December 2020

Vascular biology of atherosclerosis: overview and state of the art.

1 reference

12 December 2020

A role for oxidized phospholipids in atherosclerosis

1 reference

12 December 2020

Homocysteine lowering with folic acid and B vitamins in vascular disease

1 reference

12 December 2020

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

12 December 2020

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Triglycerides and the Risk of Coronary Heart Disease

1 reference

12 December 2020

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

1 reference

12 December 2020

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

1 reference

12 December 2020

Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease

1 reference

12 December 2020

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

12 December 2020

Atherosclerosis. the road ahead

1 reference

12 December 2020

Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis

1 reference

12 December 2020

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).

1 reference

12 December 2020

Interleukin-17: friend or foe in atherosclerosis?

1 reference

12 December 2020

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

1 reference

12 December 2020

Fibrates in CVD: a step towards personalised medicine

1 reference

12 December 2020

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

1 reference

12 December 2020

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

1 reference

12 December 2020

Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux

1 reference

12 December 2020

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

1 reference

12 December 2020

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

1 reference

12 December 2020

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease

1 reference

12 December 2020

Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study

1 reference

12 December 2020

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

1 reference

12 December 2020

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

1 reference

12 December 2020

Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease

1 reference

12 December 2020

Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin

1 reference

12 December 2020

HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis

1 reference

12 December 2020

Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation

1 reference

12 December 2020

Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis

1 reference

12 December 2020

B cell depletion reduces the development of atherosclerosis in mice

1 reference

12 December 2020

Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice

1 reference

12 December 2020

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

12 December 2020

Inflammation, atherosclerosis, and coronary artery disease

1 reference

12 December 2020

The metabolism and anti-atherogenic properties of HDL.

1 reference

12 December 2020

The role of innate immunity in atherogenesis

1 reference

12 December 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

12 December 2020

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

12 December 2020

Developmental basis of vascular smooth muscle diversity

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

1 reference

12 December 2020

(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G.

1 reference

12 December 2020

Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2

1 reference

12 December 2020

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

1 reference

12 December 2020

National Institutes of Health Center for Human Immunology Conference, September 2009

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

Adaptive immunity and atherosclerosis

1 reference

12 December 2020

The forgotten majority: unfinished business in cardiovascular risk reduction

1 reference

12 December 2020

Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia

1 reference

12 December 2020

9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response

1 reference

12 December 2020

Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk

1 reference

12 December 2020

1 reference

12 December 2020

Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells

1 reference

12 December 2020

Inhibition of IL-17A in atherosclerosis.

1 reference

12 December 2020

Modulation of atherosclerosis in mice by Toll-like receptor 2

1 reference

12 December 2020

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

1 reference

12 December 2020

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

1 reference

12 December 2020

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

1 reference

12 December 2020

The vascular biology of atherosclerosis and imaging targets

1 reference

12 December 2020

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

12 December 2020

Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?

1 reference

12 December 2020

HDL remodeling during the acute phase response

1 reference

12 December 2020

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

1 reference

12 December 2020

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

1 reference

12 December 2020

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis

1 reference

12 December 2020

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

12 December 2020

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

1 reference

12 December 2020

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21593864

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

348767

Dimensions Publication ID

1022943581

0 references

OpenCitations bibliographic resource ID

348767

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

348767